Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study

NCT06052969 is registered in ClinicalTrials.gov with Euphrates Vascular, Inc. as lead sponsor.

NCT NCT06052969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study
Lead sponsor
Euphrates Vascular, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2023
Completion date
March 15, 2026
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke ais, cerebral arterial disease